Cargando…

Changes in rheumatoid factor reflect the inflammatory response (CRP and ESR) to infliximab treatment

Detalles Bibliográficos
Autores principales:	De Rycke, L, Kruithof, E, Van Damme, N, Hoffman, IEA, Van den Bosch, F, Veys, EM, De Keyser, F
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2003
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833603/ http://dx.doi.org/10.1186/ar666

Ejemplares similares

The effect of infliximab on rheumatoid factor and anti-citrullinated cyclic peptide antibodies
por: van Damme, N, et al.
Publicado: (2002)

Induction of ANA, anti-dsDNA and anti-nucleosome antibodies following infliximab treatment in rheumatoid arthritis and spondyloarthropathy patients
por: de Rycke, LEB, et al.
Publicado: (2002)

The diagnostic value of synovial histopathology in undifferentiated inflammatory arthritis: a prospective study in 154 consecutive patients
por: Baeten, D, et al.
Publicado: (2003)

The effect of infliximab on skin lesions in a patient with scleroderma (CREST)
por: De Rycke, L, et al.
Publicado: (2004)

Differential expression and response to infliximab treatment of specific macrophage subsets in inflammatory synovitis
por: De Rycke, L, et al.
Publicado: (2004)

Sensitivity of ANA indirect immunofluorescence testing for the detection of anti-ENA antibodies
por: Hoffman, IEA, et al.
Publicado: (2002)

Diagnostic performance and predictive value of serum markers for the diagnosis of rheumatoid arthritis
por: Hoffman, IEA, et al.
Publicado: (2004)

False positivity of rheumatoid factor and antibodies to citrullinated peptides in systemic lupus erythematosus
por: Hoffman, IEA, et al.
Publicado: (2004)

Myeloid-related protein (MRP) 8 and MRP 14 in rheumatoid arthritis and spondyloarthropathy
por: De Rycke, L, et al.
Publicado: (2003)

Serum MRP8/MRP14 as a biomarker for inflammation in autoimmune arthritis
por: De Rycke, L, et al.
Publicado: (2004)

Macrophages expressing the scavenger receptor CD163: a link between immune alterations of the gut and synovial inflammation in spondyloarthropathy
por: Baeten, D, et al.
Publicado: (2001)

DAS28 best reflects the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients: validation of the DAS28 score in patients under infliximab treatment
por: Vander Cruyssen, Bert, et al.
Publicado: (2005)

Infiltration of the synovial membrane with macrophage subsets and polymorphonuclear cells reflects global disease activity in spondyloarthropathy
por: Baeten, Dominique, et al.
Publicado: (2005)

Localisation of MHC Class II/HC gp-39 complexes in synovia of rheumatoid arthritis patients using complex-specific monoclonal antibodies
por: Baeten, D, et al.
Publicado: (2003)

The Utility and Limitations of CRP, ESR and DAS28-CRP in Appraising Disease Activity in Rheumatoid Arthritis
por: Orr, Carl K., et al.
Publicado: (2018)

The presentation of the immunodominant epitope of HC gp-39 in the context of the RA-associated HLA class II molecules is specific for RA synovium
por: Baeten, D, et al.
Publicado: (2003)

Local production of soluble CD163 in the spondyloarthropathic joint
por: Baeten, D, et al.
Publicado: (2003)

Presence of anti-RNP-A and anti-RNP-C antibodies is inversely associated with renal symptoms of systemic lupus erythematosus
por: Hoffman, I, et al.
Publicado: (2003)

Synovial histopathology of psoriatic arthritis, both oligo- and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritis
por: Kruithof, Elli, et al.
Publicado: (2005)

The utility of ESR, CRP and platelets in the diagnosis of GCA
por: Chan, Fiona Li Ying, et al.
Publicado: (2019)

DAS28-CRP and DAS28-ESR cut-offs for high disease activity in rheumatoid arthritis are not interchangeable
por: Fleischmann, Roy M, et al.
Publicado: (2017)

The Association between ESR and CRP and Systemic Hypertension in Sarcoidosis
por: Mirsaeidi, Mehdi, et al.
Publicado: (2016)

ESR, CRP, and failure of Arterio-Venous Fistula (AVF)
por: Khavanin Zadeh, Morteza, et al.
Publicado: (2021)

74-week follow-up of safety of infliximab in patients with refractory rheumatoid arthritis
por: Delabaye, Isabelle, et al.
Publicado: (2010)

Discrepancies in assessment of patients with rheumatoid arthritis and secondary Sjögren's syndrome by DAS28-ESR and DAS28-CRP
por: Romanowska-Próchnicka, Katarzyna, et al.
Publicado: (2016)

Association between ASCA-positivity and carrier of a CARD-15 mutation in patients with Crohn's disease
por: van der Cruyssen, B, et al.
Publicado: (2003)

Gender stratified adjustment of the DAS28-CRP improves inter-score agreement with the DAS28-ESR in rheumatoid arthritis
por: Hamann, Philip D H, et al.
Publicado: (2019)

DAS28‐CRP Cutoffs for High Disease Activity and Remission Are Lower Than DAS28‐ESR in Rheumatoid Arthritis
por: Greenmyer, Jacob R., et al.
Publicado: (2020)

Comparison of D-dimer with CRP and ESR for diagnosis of periprosthetic joint infection
por: Xiong, Longjiang, et al.
Publicado: (2019)

Circulating bioactive TNF in rheumatoid arthritis patients treated with infliximab: link to clinical response
por: Marotte, H, et al.
Publicado: (2003)

Shared epitope and rheumatoid arthritis severity: association with infliximab treatment in a postmarketing study
por: Marotte, H, et al.
Publicado: (2003)

Polymorphism at the position -308 of TNF-α gene influences outcome of infliximab therapy in rheumatoid arthritis
por: Mugnier, B, et al.
Publicado: (2004)

The presence of deiminated fibrin in the synovial membrane is not specific for rheumatoid arthritis
por: Chapuy-Regaud, S, et al.
Publicado: (2004)

Effect of linezolid on serum PCT, ESR, and CRP in patients with pulmonary tuberculosis and pneumonia
por: Ding, Rui-Dong, et al.
Publicado: (2018)

Tumor necrosis factor-α blockade in ankylosing spondylitis: a potent but expensive anti-inflammatory treatment or true disease modification?
por: Van den Bosch, Filip, et al.
Publicado: (2005)

Low infliximab serum trough levels and anti-infliximab antibodies are prevalent in rheumatoid arthritis patients treated with infliximab in daily clinical practice: results of an observational cohort study
por: van der Maas, Aatke, et al.
Publicado: (2012)

PReS-FINAL-2021: JADAS-CRP instead of JADAS-ESR...results from REUMA.PT
por: Mourão, AF, et al.
Publicado: (2013)

Digital vasculitis in a patient with rheumatoid arthritis: good response on anti-TNF blockade
por: van den Hoogen, F, et al.
Publicado: (2001)

Four-year follow-up of infliximab therapy in rheumatoid arthritis patients with long-standing refractory disease: attrition and long-term evolution of disease activity
por: Cruyssen, Bert Vander, et al.
Publicado: (2006)

IL-18 correlates positively with CRP and IL-1Ra but not with DAS28 or bone erosion in patients with rheumatoid arthritis
por: Nielsen, H, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_61e4346fc3lhcvi8da2jjmbrnt